New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2011
08:43 EDTRNNRexahn Pharmaceuticals coverage assumed with a Buy at Brean Murray
Target $3.
News For RNN From The Last 14 Days
Check below for free stories on RNN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 24, 2014
18:19 EDTRNNOn The Fly: After Hours Movers
UP AFTER EARNINGS: Jabil Circuit (JBL), up 3.8% after reporting fourth quarter results and fiscal 2015 guidance. ALSO HIGHER: Rexahn Pharmaceuticals (RNN), up 11.8% after announcing that the FDA has granted Orphan Drug Designation for its drug RX-3117 for the treatment of patients with pancreatic cancer... xG Technology (XGTI), up 7.8% after announcing stock purchase agreements for up to $16M... Marchex (MCHX), up 2.1% after receiving notice of termination from Allstate (ALL). DOWN AFTER EARNINGS: HB Fuller (FUL), down 11.3% after reporting second quarter results and guidance below analyst estimates.
17:38 EDTRNNRexahn up nearly 10% after hours following FDA orphan drug designation
Subscribe for More Information
16:32 EDTRNNRexahn receives FDA orphan drug designation for RX-3117
Rexahn Pharmaceuticals announced that the FDA has granted Orphan Drug Designation for its drug RX-3117 for the treatment of patients with pancreatic cancer. RX-3117 is a next generation, cancer-specific nucleoside analog. Rexahn is currently enrolling patients in a Phase Ib clinical trial in cancer patients and expects to complete this trial in Q1. Preclinical studies have shown that RX-3117 maintains its anti-tumor activity in human cancer cell lines that are resistant to gemcitabine, a chemotherapy drug used to treat pancreatic cancer. Gemcitabine resistance represents a major problem in the treatment of cancer patients. In pancreatic cancer patients who have been treated with gemcitabine, up to 40% of patients became resistant to gemcitabine after 30 days.
09:05 EDTRNNRexahn treatment of pancreatic cancer granted FDA orphan designation
Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use